Cannabis and Hot Flashes
What the evidence actually says about using cannabis for menopausal vasomotor symptoms, and where the data runs out.
A lot of perimenopausal and menopausal people are trying cannabis for hot flashes, and survey data confirms it's common. But here's the truth: there is no high-quality clinical trial showing cannabis reduces hot flashes. The evidence is almost entirely self-report. Cannabis may help adjacent symptoms — sleep, anxiety, joint pain — which can make the whole experience feel better. That's not nothing. But if someone tells you a specific strain or CBD product 'treats' hot flashes, they're ahead of the science.
Not Medical Advice
This article is not medical advice. It summarizes published evidence about cannabis and menopausal hot flashes. Menopause symptoms can overlap with thyroid disease, cardiac issues, and other conditions that need a proper workup. Talk to a clinician — ideally one familiar with both menopause and cannabis — before using cannabis to manage symptoms, especially if you take other medications, have a history of cardiovascular disease, or are considering hormone therapy.
Plain-language summary
Hot flashes (vasomotor symptoms, or VMS) are sudden episodes of heat, sweating, and flushing tied to declining and fluctuating estrogen during perimenopause and menopause. They affect roughly 75% of people going through menopause and can persist for years [1].
Many people use cannabis to cope. A 2020 survey of US military veterans found that about 27% of those experiencing menopause symptoms had used cannabis to manage them, and another 10% were interested in trying [2]. A 2023 Canadian survey reported similar patterns [3].
Use is widespread. Evidence that it actually reduces hot flashes is not. No randomized controlled trial has tested cannabis, THC, or CBD specifically for VMS. What we have is self-reported symptom relief, plus indirect evidence that cannabis may help related symptoms like sleep and anxiety.
What probably works
Honestly: nothing in the cannabis category has reached this tier for hot flashes specifically.
For menopausal sleep disturbance — which is often driven by night sweats — there is moderate evidence that cannabis (particularly THC-containing products) can shorten time to sleep onset in the short term, though tolerance develops and long-term effects on sleep architecture are unfavorable [4]. Weak / limited
For menopausal anxiety and low mood, low-dose THC and CBD have some supportive trial data in anxiety disorders broadly, though not in menopause populations specifically [5]. Weak / limited
None of this is the same as reducing the hot flash itself. It may reduce the suffering around the hot flash.
What might work
Reduction in hot flash severity or bother (not frequency). In the veterans survey, users who reported cannabis for menopause symptoms most commonly cited improvements in sleep and mood, with smaller numbers reporting reduced hot flash discomfort [2]. This is self-report without a control group. Anecdote
CBD for menopausal joint and muscle pain. Extrapolating from chronic pain literature, CBD and balanced THC:CBD products show modest effects on some pain conditions [6]. Whether this generalizes to menopause-related musculoskeletal symptoms has not been tested. Weak / limited
Endocannabinoid system involvement in thermoregulation. Animal studies show CB1 receptor activation affects core body temperature, generally producing hypothermia at higher doses [7]. Whether this translates to a meaningful clinical effect on hot flashes in humans is unknown. Weak / limited
What doesn't work or has weak evidence
Specific 'menopause strains' or marketing claims. Products marketed as menopause-specific cannabis blends, suppositories, or tinctures have no clinical trial backing. The indica-vs-sativa framing predicts very little about effects Disputed, and terpene-specific claims (e.g. that linalool or myrcene 'cool' hot flashes) are not supported by controlled human data. No data
CBD alone for hot flash frequency. Despite heavy marketing, no published RCT shows isolated CBD reduces hot flash frequency. No data
Cannabis as a phytoestrogen. Cannabis is not a meaningful source of phytoestrogens, and the cannabinoid system is not an estrogen-replacement pathway. Claims otherwise are folklore. No data
What we don't know
- Whether any cannabinoid, at any dose, reduces objectively measured hot flash frequency (via skin conductance or ambulatory monitoring).
- Whether effects differ between perimenopause and postmenopause.
- Whether long-term cannabis use during menopause affects bone density, cardiovascular risk, or cognitive trajectory — all of which are already in flux during this period.
- Interactions with hormone therapy. THC and CBD both interact with cytochrome P450 enzymes that also metabolize estradiol [8], but the clinical significance is unclear.
- Optimal route (inhaled vs. oral vs. topical), dose, or ratio.
If someone gives you confident answers to any of the above, they are guessing.
Comparison with standard treatments
Menopausal hormone therapy (MHT/HRT) remains the most effective treatment for moderate-to-severe vasomotor symptoms, reducing hot flash frequency by roughly 75% in randomized trials [1, 9]. Strong evidence For most healthy people under 60 or within 10 years of menopause onset, benefits outweigh risks; this is the position of the North American Menopause Society [9].
Non-hormonal pharmaceuticals with controlled evidence for hot flashes include SSRIs/SNRIs (paroxetine is FDA-approved for VMS), gabapentin, oxybutynin, and the newer NK3-receptor antagonist fezolinetant [1, 9]. Strong evidence
Cannabis has no comparable evidence base. It should not be considered a substitute for treatments that work. It may be a reasonable adjunct for sleep or anxiety in someone who is already an informed cannabis user — but that is a different claim than 'cannabis treats hot flashes.'
Risks
- Cardiovascular. Menopause raises cardiovascular risk. Cannabis use, particularly inhaled, is associated with increased risk of acute cardiac events in observational data [10]. This matters more in this population than in younger users.
- Cognitive and mood effects. Perimenopause already involves cognitive complaints (the 'brain fog' people report). THC can worsen short-term memory and concentration; in some users it worsens anxiety.
- Sleep rebound. Regular nightly THC use can disrupt REM sleep and produce withdrawal-related insomnia when stopped — worsening the very symptom people are trying to treat.
- Drug interactions. CBD inhibits CYP3A4 and CYP2C19, which can raise levels of many medications including some used in perimenopause [8].
- Dependence. Cannabis use disorder occurs in roughly 9–10% of adult users, higher with daily use [11].
- Regulatory. No cannabis product is approved anywhere for menopause. Products are inconsistently labeled and sometimes contaminated.
Bottom line
Cannabis is not a treatment for hot flashes in any evidence-based sense. It may help some of the things that travel with hot flashes — poor sleep, anxiety, joint pain — but the data are weak and the population studies on menopause specifically are nearly absent. If hot flashes are disrupting your life, the conversation worth having with a clinician is about hormone therapy or evidence-based non-hormonal medications first. Cannabis can be part of a personal toolkit, but call it what it is: a coping tool, not a treatment.
See also: Cannabis and Sleep, Cannabis and Anxiety, CBD: Evidence Overview.
Sources
- Peer-reviewed Avis NE, Crawford SL, Greendale G, et al. Duration of menopausal vasomotor symptoms over the menopause transition. JAMA Internal Medicine. 2015;175(4):531-539.
- Peer-reviewed Slavin MN, Farmer S, Earleywine M. Cannabis use to manage menopause symptoms among midlife women veterans. Menopause. 2020;27(11):1235-1242.
- Peer-reviewed Dahlgren MK, El-Abboud C, Lambros AM, et al. A survey of medical cannabis use during perimenopause and postmenopause. Menopause. 2022;29(9):1028-1036.
- Peer-reviewed Babson KA, Sottile J, Morabito D. Cannabis, cannabinoids, and sleep: a review of the literature. Current Psychiatry Reports. 2017;19(4):23.
- Peer-reviewed Bergamaschi MM, Queiroz RH, Chagas MH, et al. Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patients. Neuropsychopharmacology. 2011;36(6):1219-1226.
- Government National Academies of Sciences, Engineering, and Medicine. The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research. Washington, DC: National Academies Press; 2017. ↗
- Peer-reviewed Fraga D, Zanoni CI, Rae GA, Parada CA, Souza GE. Endogenous cannabinoids induce fever through the activation of CB1 receptors. British Journal of Pharmacology. 2009;157(8):1494-1501.
- Peer-reviewed Brown JD, Winterstein AG. Potential adverse drug events and drug-drug interactions with medical and consumer cannabidiol (CBD) use. Journal of Clinical Medicine. 2019;8(7):989.
- Peer-reviewed The 2022 Hormone Therapy Position Statement of The North American Menopause Society. Menopause. 2022;29(7):767-794.
- Peer-reviewed Mittleman MA, Lewis RA, Maclure M, Sherwood JB, Muller JE. Triggering myocardial infarction by marijuana. Circulation. 2001;103(23):2805-2809.
- Peer-reviewed Hasin DS, Saha TD, Kerridge BT, et al. Prevalence of marijuana use disorders in the United States between 2001-2002 and 2012-2013. JAMA Psychiatry. 2015;72(12):1235-1242.
How this page was made
Generation history
Drafting assistance and fact-check automation are used, with a human operator spot-checking on a weekly basis. See how articles are made.
Related
- Cannabis and Chronic Pain — What the evidence actually says about cannabis for long-term pain, separated from the mark...